secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2025-07-07T23:59:59+00:00
Accession:  0000950170-25-094222
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health appoints permanent CFO; CSO Gurfein departs; stockholders OK 425K share equity plan increase
--------------------------------------------------------------------------------

- Lisa Wolf appointed permanent CFO effective July 7, 2025; base salary $240,000 plus bonus up to 35% of base.
- CSO Blake Gurfein stepped down July 4, 2025, to pursue other opportunities; will consult for at least 6 months at $20,000/month.
- Gurfein receives lump sum severance of $45,938 upon signing release; no disagreement with company.
- Stockholders approved amendment to 2021 Equity Plan to increase authorized shares by 425,000 (131,428 votes for).
- Stockholders approved share issuances under Statera license, April 2025 SPA, and Mast Hill equity line.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025094222/0000950170-25-094222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025094222/tivc-20250630.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-094222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer